Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Blobel Friedhelm
Relationship:   President, CEO, Direct...
City:   San Mateo
State:   CA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   0    

Indirect Shares

  0      
Direct Value   $0    

Indirect Value

  $0      
Total Shares   0      
Total Value   $0      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Sciclone Pharmaceuticals Inc SCLN President, CEO, Direct... 2017-10-13 0 2007-11-20 0    Premium*  
* Premium Members only  

Records found :    173         Free Registration Required For Full Results.    Limit: 25

Download
  Page 4 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-06-08 4 AS $11.00 $219,608 D/D (19,956) 93,299 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2016-12-22 4 OE $1.81 $12,491 D/D 6,901 93,685 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-26 4 OE $3.55 $4,970 D/D 1,400 93,926 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-03 4 OE $1.08 $30,447 D/D 13,296 94,039 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-27 4 OE $3.55 $9,940 D/D 2,800 95,326 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-25 4 OE $1.08 $9,577 D/D 8,868 95,652 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-05 4 OE $1.81 $16,652 D/D 9,200 95,984 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-22 4 OE $1.08 $9,937 D/D 9,201 95,985 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-23 4 OE $1.08 $10,584 D/D 9,800 96,584 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-01 4 OE $1.08 $9,936 D/D 9,200 96,726 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-06-02 4 OE $3.55 $17,040 D/D 4,800 98,099 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-06-06 4 OE $3.55 $19,525 D/D 5,500 98,799 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-05-24 4 OE $3.55 $22,358 D/D 6,298 98,824 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-01-20 4 OE $1.81 $22,444 D/D 12,400 99,184 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2016-11-22 4 OE $1.81 $25,606 D/D 14,147 100,931 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-03-22 4 OE $3.55 $34,300 D/D 9,662 102,188 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-20 4 OE $3.55 $41,457 D/D 11,678 104,204 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-24 4 OE $3.55 $43,168 D/D 12,160 104,686 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-02-21 4 OE $1.08 $21,790 D/D 20,176 106,960 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-05-23 4 OE $3.55 $53,839 D/D 15,166 107,692 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-04-21 4 OE $3.55 $57,375 D/D 16,162 108,688 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-05-11 4 OE $3.55 $64,702 D/D 18,226 110,752 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-05-22 4 OE $3.55 $65,803 D/D 18,536 111,062 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2016-11-14 4 OE $1.81 $44,705 D/D 24,699 111,483 0 -
SCLN Sciclone Pharmaceuticals ... President & CEO   •       •      –    2017-06-07 4 OE $3.55 $69,935 D/D 19,700 112,999 0 -

  173  Records found
  1   2   3   4  5   6   7      
  Page 4 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed